Evidence that general genomic hypomethylation and focal hypermethylation are two independent molecular events of non-Hodgkin's lymphoma

Oncology Research

Volumn 14, Issue 7-8, 2004, Pages 399-405

  Pini, Janelle T ^a   Franchina, Maria ^a   Taylor, Jeremy M E ^b   Kay, Peter H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Western Australian Centre for Pathology and Medical Research   (Australia)

Author keywords

Genomic hypomethylation; Hypermethylation; Malignant lymphoproliferative disorders; Myf 3; PAX7

Indexed keywords

MYF 3 PROTEIN; MYOGENIC FACTOR; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FOCAL HYPERMETHYLATION; GENOMIC HYPOMETHYLATION; HUMAN; HUMAN CELL; LYMPHOID CELL; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT TRANSFORMATION; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL;

EID: 4043057968     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/0965040041292323     Document Type: Article

References (22)

1. Holliday, R.; Ho, T. Evidence for gene silencing by endogenous DNA methylation. Proc. Natl. Acad. Sci. USA 95:8727-8732; 1998.
2. Kanduri, C.: Raman, R. Characterisation of developmentally regulated chromatin structure in the coding region of the proto-oncogene, c-fos, in the male laboratory mouse. Int. J. Dev. Biol. 43:279-282; 1999.
3. Kay, P. H.; Taylor, J.; Kees, U. R.; Baker, D. L.; Spagnolo, D. V. Myf-3 hypermethylation in malignant lymphoproliferative disorders. Int. J. Cancer 62:797-799; 1995.
4. Laird, P. W.; Jackson-Grusby, L.; Fazeli, A.; Dickinson, S. L.; Jung, W. E.; Li, E.; Weinberg, R. A.; Jaenisch, R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81:197-205; 1995.
5. Pelham, J. T.; Irwin, P. J.; Kay, P. H. Genomic hypomethylation in neoplastic cells from dogs with malignant lymphoproliferative disorders. Res. Vet. Sci. 74:101-104; 2003.
6. Wainfan, E.; Poirier, L. A. Methyl groups in carcinogenesis: Effects on DNA methylation and gene expression. Cancer Res. 52:2071-2077; 1992.
7. Iacopetta, B. J.; Harmon, D.; Spagnolo, D. V.; House, A. K.; Kay, P. H. Hypermethylation of the Myf-3 gene in human colorectal cancer. Anticancer Res. 17:429-432; 1997.
8. Ehrlich, M.; Jiang, G.; Fiala, E.; Dome, J. S.; Yu, M. C.; Long, T. I.; Youn, B.; Sohn, O.-S.; Widschwendter, M.; Tomlinson, G. E.; Chintagumpala, M.; Champagne, M.; Parham, D.; Liang, G.; Malik, K.; Laird, P. Hypomethylation and hypermethylation of DNA in Wilms tumors. Oncogene 21:6694-6702; 2002.
9. Kay, P. H.; Spagnolo, D. V.; Taylor, J.; Ziman, M. DNA methylation and developmental genes in lymphomagenesis-more questions than answers. Leukemia Lymphoma 24:211-220; 1997.
10. Schafer, B. W.; Czerny, T.; Barnasconi, M.; Genini, M.; Busslinger, M. Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. Nucleic Acid Res. 22:4574-4582; 1994.
11. Golbus, J.; Palella, T. D.; Richardson, B. C. Quantitative changes in T cell DNA methylation occur during differentiation and ageing. Eur. J. Immunol. 20:1869-1872; 1990.
12. Maniatis, T.; Fritsch, E. F.; Sambrook, J. Molecular cloning: A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1982.
13. Taylor, J. M. E.; Kay, P. H.; Spagnolo, D. V. The diagnostic significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders. Leukemia 15:583-589; 2001.
14. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 95:503-509; 1975.
15. Wahlfors, J.; Hiltunen, H.; Heinonen, K.; Hamalainen, E.; Alhonen, L.; Janne, J. J. Genomic hypomethylation in human chronic lymphocytic leukemia. Blood 80:2074-2080; 1992.
16. Baylin, S. B.; Bestor, T. H. Altered methylation patterns in cancer cell genomes: Cause or consequence? Cancer Cell 1:299-305; 2002.
17. Shu-Xia, G.; Tomohiko, T.; Hiroaki, O.; Hui-Ying, P.; Ken, T.; Fumio, B.; Ryoji, H.; Masayoshi, Y.; Yasuhide, H. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia. Leukemia Res. 24:39-46; 2002.
18. Ueki, T.; Toyota, M.; Sohn, T.; Yeo, C. J.; Issa, J. P.; Hruban, R. H.; Goggins, M. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 60: 1835-1839; 2000.
19. van Rijnsoever, M.; Grieu, F.; Elsaleh, H.; Joseph, D.; Iacopetta, B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51:797-802; 2002.
20. Bestor, T.; Laudano, A.; Mattaliano, R.; Ingram, V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells: The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J. Mol. Biol. 203:971-983; 1988.
21. Bhattacharya, S. K.; Ramchandani, S.; Cervoni, N.; Szyf, M. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397:579-583; 1999.
22. Vogelstein, B.; Kinzler, K. W. The multistep nature of cancer. Trends Genet. 9:138-141; 1993.